Zacks Research Has Negative Estimate for TSE:BHC Q4 Earnings

Bausch Health Companies Inc. (TSE:BHC) – Stock analysts at Zacks Research dropped their Q4 2025 earnings estimates for shares of Bausch Health Companies in a research report issued on Tuesday, December 23rd. Zacks Research analyst Team now anticipates that the company will earn $1.63 per share for the quarter, down from their previous forecast of $1.66. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q1 2026 earnings at $1.13 EPS, Q3 2026 earnings at $1.50 EPS, FY2026 earnings at $5.37 EPS, Q2 2027 earnings at $1.32 EPS, Q3 2027 earnings at $1.42 EPS and FY2027 earnings at $5.30 EPS.

Other analysts also recently issued reports about the stock. Barclays upgraded shares of Bausch Health Companies to a “hold” rating in a research report on Monday, December 8th. Raymond James Financial raised Bausch Health Companies to a “hold” rating in a report on Monday, December 15th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Bausch Health Companies Trading Down 2.0%

Bausch Health Companies stock opened at C$9.84 on Thursday. Bausch Health Companies has a 12-month low of C$5.91 and a 12-month high of C$11.97. The firm has a market capitalization of C$3.65 billion, a price-to-earnings ratio of 10.14, a P/E/G ratio of 0.21 and a beta of 0.69. The firm has a 50 day moving average of C$9.19 and a 200 day moving average of C$9.16. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94.

Bausch Health Companies (TSE:BHC) last announced its earnings results on Wednesday, October 29th. The company reported C$0.48 earnings per share (EPS) for the quarter. The company had revenue of C$2.68 billion during the quarter. Bausch Health Companies had a negative net margin of 1.88% and a positive return on equity of 15.87%.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.